Rhythm Biosciences Gets CE Mark for Colorectal Cancer Test

Melbourne, Australia-based Rhythm Biosciences has received a CE mark for its ColoSTAT blood test for the detection of colorectal cancer.

The immunoassay measures the presence of multiple protein biomarkers for colorectal cancer that were identified by Australia's Commonwealth Scientific and Industrial Research Organization.

Rhythm Biosciences says the simple blood test “has the potential to become the new first-step screening test” for people who choose not to participate in the existing screening programs for colorectal cancer.